Keywords: Forest Labs, Share buy-back, Shareholder value

Forest Labs repurchases $350 million additional shares

Article | 16 August 2011

Print This

US drugmaker Forest Laboratories (NYSE: FRX), which is an ongoing battle with billionaire investor Carl Icahn who is trying to ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in